The Group values input and feedback of its stakeholders as they are closely connected to the Group’s development. Internal and external stakeholders have been involved in regular engagement activities to share their views regarding the Group’s operations and performances, which are as shown below.

DNA diagnostics is a rapidly evolving field that utilizes genetic analysis to diagnose, detect, and monitor various diseases and conditions. By examining an individual’s genetic material, DNA diagnostics provides critical insights into inherited disorders, infectious diseases, cancer, and even pharmacogenomics (how a person’s genes affect their response to medications). This field has revolutionized healthcare by enabling early disease detection, personalized medicine, and targeted therapies. With the advancements in molecular biology and sequencing technologies, DNA diagnostics is becoming more accessible, accurate, and affordable, paving the way for significant medical and scientific breakthroughs.

CDMOs serve companies in the pharmaceutical industry on a contract basis. They provide pharmaceutical companies with comprehensive services that range from drug development to drug manufacturing.

Gait biometrics refers to the technology that is used to measure body movement along with the force and pressure exerted while moving. It is used to identify, track, and treat individuals by understanding their body movements.

Global CRO Market Size and Share Analysis - Growth Trends and Forecasts (2025 - 2030)

社会服务行业：理性消费与结构复苏并行，关注情绪消费－2025下半年社会服务投资策略-申万宏源

Global Automated Cell Culture Systems Market - Growth Trends and Forecasts (2025 - 2030)